Mortality in a large population-based cohort of patients with drug-treated diabetes mellitus.
S V Koskinen,
A R Reunanen,
T P Martelin and
T Valkonen
Department of Health and Disability, National Public Health Institute, Helsinki, Finland. seppo.koskinen@ktl.fi
OBJECTIVES: This paper presents detailed cause-specific dataabout excess mortality among diabetic persons in Finland, byage and sex. METHODS: Five-year follow-up data on the Finnishpopulation aged 30 through 74 years were analyzed. During these5 years, 11,215 persons with diabetes and 102,843 persons withoutdiabetes died. The diabetic population was defined as peoplewho were entitled to free medication for diabetes at the beginningof the follow-up period, that is, at the end of 1980. RESULTS:The relative mortality of persons with drug-treated diabetescompared with nondiabetic persons was higher among women (3.4)than among men (2.4). Almost three quarters of the mortalityexcess was due to circulatory diseases. For most other causesof death, too, diabetic persons had higher than average mortality.The exceptions were lung cancer, chronic obstructive pulmonarydisease, and alcohol poisoning. CONCLUSIONS: Diabetes is a generalrisk factor for untimely death and makes a significant contributionto overall national death rates, particularly for circulatorydiseases. Lower than average mortality from smoking-relateddiseases and alcohol poisoning, however, warrant optimism aboutthe effects of health education among diabetic persons.
This article has been cited by other articles:
S. F. Ehrlich, C. P. Quesenberry Jr., S. K. Van Den Eeden, J. Shan, and A. Ferrara Patients Diagnosed With Diabetes Are at Increased Risk for Asthma, Chronic Obstructive Pulmonary Disease, Pulmonary Fibrosis, and Pneumonia but Not Lung Cancer
Diabetes Care,
January 1, 2010;
33(1):
55 - 60.
[Abstract][Full Text][PDF]
H. Zaman Huri, Lee Qiu Yi, R. Pendek, and Che Zuraini Sulaiman Use of Antiplatelet Agents for Primary and Secondary Prevention of Cardiovascular Disease Amongst Type 2 Diabetic Patients
Journal of Pharmacy Practice,
August 1, 2008;
21(4):
287 - 301.
[Abstract][PDF]
L. N. McEwen, C. Kim, A. J. Karter, M. N. Haan, D. Ghosh, P. M. Lantz, C. M. Mangione, T. J. Thompson, and W. H. Herman Risk Factors for Mortality Among Patients With Diabetes: The Translating Research Into Action for Diabetes (TRIAD) Study
Diabetes Care,
July 1, 2007;
30(7):
1736 - 1741.
[Abstract][Full Text][PDF]
A. Nicolucci, S. Greenfield, and S. Mattke Selecting indicators for the quality of diabetes care at the health systems level in OECD countries
Int. J. Qual. Health Care,
September 1, 2006;
18(suppl_1):
26 - 30.
[Abstract][Full Text][PDF]
S. S. Coughlin, E. E. Calle, L. R. Teras, J. Petrelli, and M. J. Thun Diabetes Mellitus as a Predictor of Cancer Mortality in a Large Cohort of US Adults
Am. J. Epidemiol.,
June 15, 2004;
159(12):
1160 - 1167.
[Abstract][Full Text][PDF]
G. Verlato, G. Zoppini, E. Bonora, and M. Muggeo Mortality From Site-Specific Malignancies in Type 2 Diabetic Patients From Verona
Diabetes Care,
April 1, 2003;
26(4):
1047 - 1051.
[Abstract][Full Text][PDF]
S. L. Krein, S. Vijan, L. M. Pogach, M. M. Hogan, and E. A. Kerr Aspirin Use and Counseling About Aspirin Among Patients With Diabetes
Diabetes Care,
June 1, 2002;
25(6):
965 - 970.
[Abstract][Full Text][PDF]
N. A. Roper, R. W. Bilous, W. F. Kelly, N. C. Unwin, and V. M. Connolly Cause-Specific Mortality in a Population With Diabetes: South Tees Diabetes Mortality Study
Diabetes Care,
January 1, 2002;
25(1):
43 - 48.
[Abstract][Full Text][PDF]
N. A Roper, R. W Bilous, W. F Kelly, N. C Unwin, and V. M Connolly Excess mortality in a population with diabetes and the impact of material deprivation: longitudinal, population based study
BMJ,
June 9, 2001;
322(7299):
1389 - 1393.
[Abstract][Full Text][PDF]
B. Balkau, H. S. Kahn, D. Courbon, E. Eschwège, and P. Ducimetière Hyperinsulinemia Predicts Fatal Liver Cancer but Is Inversely Associated With Fatal Cancer at Some Other Sites: The Paris Prospective Study
Diabetes Care,
May 1, 2001;
24(5):
843 - 849.
[Abstract][Full Text]
D. N. Rose Benefits of Screening for Latent Mycobacterium tuberculosis Infection
Arch Intern Med,
May 22, 2000;
160(10):
1513 - 1521.
[Abstract][Full Text][PDF]